THALOMID Trademark

Trademark Overview

On Thursday, October 2, 1997, a trademark application was filed for THALOMID with the United States Patent and Trademark Office. The USPTO has given the THALOMID trademark a serial number of 75366782. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, May 10, 2018. This trademark is owned by Celgene Corporation. The THALOMID trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, cytokine inhibitory drugs
thalomid

General Information

Serial Number75366782
Word MarkTHALOMID
Filing DateThursday, October 2, 1997
Status800 - REGISTERED AND RENEWED
Status DateThursday, May 10, 2018
Registration Number2242095
Registration DateTuesday, April 27, 1999
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 21, 1998

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, cytokine inhibitory drugs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 10, 1997
Primary Code005
First Use Anywhere DateTuesday, September 29, 1998
First Use In Commerce DateTuesday, September 29, 1998

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059

Trademark Events

Event DateEvent Description
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 10, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, May 10, 2018REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Thursday, May 10, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, May 10, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 1, 2018TEAS SECTION 8 & 9 RECEIVED
Friday, April 27, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, July 29, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 30, 2008REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, May 30, 2008REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, May 22, 2008ASSIGNED TO PARALEGAL
Monday, May 12, 2008TEAS SECTION 8 & 9 RECEIVED
Tuesday, July 17, 2007CASE FILE IN TICRS
Thursday, June 16, 2005TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 14, 2004REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, May 10, 2004REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Monday, July 29, 2002TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 27, 1999REGISTERED-PRINCIPAL REGISTER
Thursday, February 25, 1999ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 23, 1999ASSIGNED TO EXAMINER
Friday, February 19, 1999STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 27, 1999USE AMENDMENT FILED
Tuesday, October 13, 1998NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 21, 1998PUBLISHED FOR OPPOSITION
Friday, June 19, 1998NOTICE OF PUBLICATION
Monday, May 18, 1998APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 16, 1998ASSIGNED TO EXAMINER

Related Keywords

thalomid inhibitory drugs cytokine namely preparations pharmaceutical